A Mouse Model for Microbeam Radiation Therapy of the Lung.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33383127.
- Also identified by DOI 10.1016/j.ijrobp.2020.12.030.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Radiation therapy is an important treatment component for patients with lung cancer. However, the survival time gained with clinical radiation therapy techniques is relatively short. Data from preclinical experiments suggest that synchrotron microbeam radiation therapy could be much better suited to control malignant brain tumors than current clinical concepts of radiation therapy. Even at peak doses of several hundred gray, the extent of functional deficits is low. We have developed the first mouse model to study the effects of microbeam irradiation in lung tissue. Up to peak doses of 400 Gy, no acute adverse effects were seen. This model is well suited to explore the potential of microbeam radiation therapy in the treatment of lung cancer and the response of normal lung tissue and organs at risk.
Medical subject headings
- Disease Models, Animal
- Lung
- Synchrotrons